Bosh sahifaALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
9,65 $
Seans yopilganidan keyin:(0,15%)+0,014
9,66 $
Yopilgan:6-iyn, 16:11:24 (GMT-4) · USD · OTCMKTS · Ogohlantirish
Yopilish kursi
9,66 $
Kunlik diapazon
9,61 $ - 10,07 $
Yillik diapazon
8,37 $ - 13,14 $
Bozor kapitalizatsiyasi
2,53 trln JPY
Oʻrtacha hajm
131,61 ming
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 459,29 mlrd | 10,78% |
Joriy xarajat | 328,33 mlrd | 16,59% |
Sof foyda | 74,90 mlrd | 325,06% |
Sof foyda marjasi | 16,31 | 303,11% |
Har bir ulushga tushum | — | — |
EBITDA | 101,78 mlrd | -6,11% |
Amaldagi soliq stavkasi | -23,68% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 188,37 mlrd | -43,88% |
Jami aktivlari | 3,34 trln | -6,44% |
Jami passivlari | 1,83 trln | -7,46% |
Umumiy kapital | 1,51 trln | — |
Tarqatilgan aksiyalar | 1,79 mlrd | — |
Narxi/balansdagi bahosi | 0,01 | — |
Aktivlardan daromad | 3,98% | — |
Kapitaldan daromad | 5,69% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 74,90 mlrd | 325,06% |
Operatsiyalardan naqd pul | 101,08 mlrd | 40,42% |
Sarmoyadan naqd pul | -2,96 mlrd | 86,62% |
Moliyadan naqd pul | -90,81 mlrd | -393,61% |
Naqd pulning sof oʻzgarishi | 8,51 mlrd | -89,59% |
Boʻsh pul | 50,68 mlrd | -8,05% |
Haqida
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Tashkil etilgan
1-apr, 2005
Bosh ofis
Sayt
Xodimlar soni
14 754
